COPD stage and risk of hospitalization for infectious disease

Chest

Volumn 134, Issue 1, 2008, Pages 46-53

  Benfield, Thomas ^a   Lange, Peter ^b   Vestbo, Jørgen ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

COPD; Epidemiology; Hospitalization; Infection; Lung function

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DENMARK; DISEASE COURSE; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INFECTION; INFECTION RATE; INFECTION RISK; INFECTIOUS DIARRHEA; INFLUENZA; LOWER RESPIRATORY TRACT INFECTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PLEURA EMPYEMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RATING SCALE; SEPSIS; SKIN INFECTION; TUBERCULOSIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

EID: 47549086394     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-2933     Document Type: Article

References (28)

1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367:1747-1757
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3:e442
3. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002: 1-16
4. Vestbo J, Hogg JC. Convergence of the epidemiology and pathology of COPD. Thorax 2006; 61:86-88
5. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106:196-204
6. Paggiaro PL, Dahle R, Bakran I, et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease: international COPD Study Group. Lancet 1998; 351:773-780
7. Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320:1297-1303
8. Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353:1819-1823
9. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356:775-789
10. Greenberg SB, Allen M, Wilson J, et al. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:167-173
11. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001; 164:358-364
12. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57:847-852
13. Kanner RE, Renzetti AD Jr, Klauber MR, et al. Variables associated with changes in spirometry in patients with obstructive lung diseases. Am J Med 1979; 67:44-50
14. Appleyard M. The Copenhagen City Heart Study: Oster-broundersogelsen; a book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). The Copenhagen City Heart Study Group. Scand J Soc Med Suppl 1989; 41:1-160
15. Pedersen CB, Gotzsche H, Moller JO, et al. The Danish Civil Registration System: a cohort of eight million persons. Dan Med Bull 2006; 53:441-449
16. Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 2007; 50:549-554
17. Lange P, Nyboe J, Jensen G, et al. Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J 1991; 4:1080-1087
18. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-1200
19. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006. Global Strategy for the Diagnosis, Management and Prevention of COPD. Available at: www.goldcopd.com. Accessed May 20, 2008
20. Benfield TL, Dahl M, Nordestgaard BG, et al. Influence of the factor V Leiden mutation on infectious disease susceptibility and outcome: a population-based study. J Infect Dis 2005; 192:1851-1857
21. Bates MN, Khalakdina A, Pai M, et al. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167:335-342
22. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
23. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumonia: a prospective study of a general population. Eur Respir J 1995; 8:1694-1698
24. Pastor P, Medley F, Murphy TV. Invasive pneumococcal disease in Dallas County, Texas: result from population-based surveillance in 1995. Clin Infect Dis 1998; 26:590-595
25. Almirall J, Bolibar I, Balanzo X, et al. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 1999; 13:349-355
26. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. N Engl J Med 2000; 342:681-689
27. Benfield T, Espersen F, Frimodt-Moller N, et al. Increasing incidence but decreasing in-hospital mortality of adult Staph-ylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007; 13:257-263
28. Ernst P, Gonzalez AV, Brassard P, et al. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007; 176:162-166